A human study to evaluate the safety and effectiveness of HemoHIM on exercise performance and fatigue improvement

Seoul National University0 个研究点目标入组 100 人开始时间: 待定最近更新: 2020年4月21日

试验速览

暂无简介。

•Healthy adults men and women aged 30 to under 60 who complain of fatigue (28 or more on the fatigue scale)

•1) Subject who is unable to perform cycle ergometer test
•2) Subject who constantly exercised (moderate or high-intensity) for 3 months prior to the first visit
•3) Those with a high level of cardiopulmonary endurance (maximum oxygen consumption of 1st and 2nd grade of 50% depending on age)
•4) Subject has a body mass index (BMI) of 18.5 kg / m2 or less or 30 kg / m2 or more
•5) Subject is over alcoholic
•6) Smoker and drug addict
•7) Insomnia
•8) Subject have any of the following (including past medical history) or are taking any related medicines: hyperlipidemia, asthma, musculoskeletal disorder and etc
•9) Subject who had a surgical operation 6 months prior to the first visit
•10) Subjects who consumed oriental medicine within 1 month prior to the first visit
•11) Subjects who consumed functional foods or related food to affect physical performance and fatigue (health supplements, fatigue recover supplements and so on)
•12) Subject with hypersensitivity to the test food or ingredients contained in the test food
•13) Subject who are pregnant or lactating women
•14) Subject in other clinical trials within one month of the first visit or plan to participate in other clinical trials during this human study period
•15) Subject unable to use smartphone
•16) Any condition that the principal investigator believes the subject is unsuitable for this study

发起方